Growth Metrics

Organogenesis Holdings (ORGO) Non-Current Debt: 2017-2023

Historic Non-Current Debt for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2023 value amounting to $60.7 million.

  • Organogenesis Holdings' Non-Current Debt fell 9.60% to $56.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $56.2 million, marking a year-over-year decrease of 9.60%. This contributed to the annual value of $60.7 million for FY2023, which is 8.28% down from last year.
  • Per Organogenesis Holdings' latest filing, its Non-Current Debt stood at $60.7 million for FY2023, which was down 8.28% from $66.2 million recorded in FY2022.
  • Organogenesis Holdings' 5-year Non-Current Debt high stood at $70.8 million for FY2021, and its period low was $39.6 million during FY2019.
  • Its 3-year average for Non-Current Debt is $65.9 million, with a median of $66.2 million in 2022.
  • As far as peak fluctuations go, Organogenesis Holdings' Non-Current Debt surged by 87.41% in 2019, and later dropped by 8.28% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Non-Current Debt (Yearly) stood at $39.6 million in 2019, then reached $39.7 million in 2019, then reached $49.6 million in 2019, then soared by 87.41% to $49.6 million in 2019, then grew by 20.88% to $60.0 million in 2020, then climbed by 17.95% to $70.8 million in 2021, then fell by 6.41% to $66.2 million in 2022, then dropped by 8.28% to $60.7 million in 2023.